Research location
Sherbrooke
Canada
Advertisement
Research activity in Sherbrooke
CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 60 trials and 61 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Sherbrooke
60 linked trials · page 2 of 2ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation
COMPLETED
26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT00463567 · 2007-04-01 · 1 site observation
COMPLETED
Switch Study of Existing Atypical Antipsychotics to BifeprunoxNCT00347425 · 2006-12-01 · 1 site observation
COMPLETED
Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)NCT00404547 · 2006-11-01 · 1 site observation
COMPLETED
Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)NCT00297115 · 2006-03-01 · 1 site observation
COMPLETED
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's DiseaseNCT00857233 · 2004-06-01 · 1 site observation
TERMINATED
Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)NCT00086671 · 2004-04-01 · 1 site observation
COMPLETED
A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.NCT00703755 · 2003-03-01 · 1 site observation
COMPLETED
GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 DiabetesNCT00280865 · 2002-04-01 · 1 site observation
COMPLETED
Tamoxifen in Treating Women With High-Risk Breast CancerNCT00002542 · 1993-07-20 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.